Related Experiment Video
Updated: May 16, 2026

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Respiratory and sleep disorders in mucopolysaccharidosis
Kenneth I Berger1, Simone C Fagondes, Roberto Giugliani
1Department Medicine, Physiology and Neuroscience, André Cournand Pulmonary Physiology Laboratory, Bellevue Hospital, New York University School of Medicine, New York, NY, USA. Kenneth.Berger@nyumc.org
Abstract:
MPS encompasses a group of rare lysosomal storage disorders that are associated with the accumulation of glycosaminoglycans (GAG) in organs and tissues. This accumulation can lead to the progressive development of a variety of clinical manifestations. Ear, nose, throat (ENT) and respiratory problems are very common in patients with MPS and are often among the first symptoms to appear. Typical features of MPS include upper and lower airway obstruction and restrictive pulmonary disease, which can lead to chronic rhinosinusitis or chronic ear infections, recurrent upper and lower respiratory tract infections, obstructive sleep apnoea, impaired exercise tolerance, and respiratory failure. This review provides a detailed overview of the ENT and respiratory manifestations that can occur in patients with MPS and discusses the issues related to their evaluation and management.
Insights
Mucopolysaccharidoses (MPS) cause glycosaminoglycan (GAG) buildup, leading to common ear, nose, throat (ENT), and respiratory issues. This review details these manifestations and their management in MPS patients.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Mucopolysaccharidoses (MPS) are rare genetic lysosomal storage disorders.
- Characterized by the accumulation of glycosaminoglycans (GAGs) in various tissues.
- This accumulation leads to progressive multi-systemic clinical manifestations.
Purpose of the Study:
- To provide a comprehensive overview of Ear, Nose, and Throat (ENT) and respiratory problems in MPS.
- To discuss the evaluation and management strategies for these manifestations.
- To highlight the early and common occurrence of ENT and respiratory symptoms in MPS patients.
Main Methods:
- Literature review of existing studies on MPS.
- Analysis of clinical manifestations related to ENT and respiratory systems.
- Discussion of diagnostic and therapeutic approaches.
Main Results:
- ENT and respiratory issues are highly prevalent in MPS, often presenting early.
- Common manifestations include airway obstruction, restrictive pulmonary disease, chronic infections, and sleep apnea.
- These symptoms significantly impact quality of life and can lead to severe complications like respiratory failure.
Conclusions:
- ENT and respiratory problems are critical components of MPS clinical presentation.
- Timely evaluation and appropriate management are essential for improving patient outcomes.
- Further research into specialized interventions for these manifestations is warranted.
More Related Videos
Related Concept Videos
Other Pulmonary Disorders
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-III
Sleep Apnea
The condition is more prevalent among...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

